Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04161040 · ClinicalTrials.gov registry record · NA

Laboratory Model for Relapse to Sedentary Behavior

A NA study, sponsored by West Virginia University.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT04161040: Completed NA study, sponsored by West Virginia University.

NCT04161040 is a NA study that has completed, run by West Virginia University. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04161040, a NA study, has completed, sponsored by West Virginia University.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

Physical inactivity is a key risk factor for noncommunicable illnesses such as cancer and cardiovascular disease-the two leading causes of death in West Virginia. The World Health Organization recommends muscle-strengthening activities 2 or more days per week and a minimum of either 150 minutes of moderate-intensity activity or 75 minutes of vigorous-intensity activity per week. Yet, only one in five adults in the United States meets these recommendations. Even more alarming is that 33.2% of West Virginians report that they did not engage in any physical activity in the past month. Incentive-based interventions increase physical activity in the short term, but incentives for healthy behavior are generally discontinued after some period of time, and relapse of unhealthy behavior is common. Thus, there is a critical need to develop interventions that result in both immediate and lasting engagement in activity. The overall objective and specific aim of the proposed project is to evaluate a brief laboratory model of relapse into sedentary behavior following incentive-based interventions that is based on Behavioral Momentum Theory. The central hypothesis is that incentives will increase activity, but relapse will occur in the brief model, like what occurs in extended clinical treatment. Development of a laboratory model of relapse into sedentary behavior (the expected outcome of the proposed project) will inform future translational research, eventually leading to clinical applications of large-scale physical-activity interventions that result in significant and immediate behavior change and that minimize relapse.

Primary Outcome

Trained research assistants will use software to score time-stamped duration of engagement in physical activity (defined as walking or running on the treadmill).

Interventions

  • BEHAVIORAL Performance-based incentives

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2019-12-09
Est. Completion 2022-03-15
Phase NA
West Virginia University

122 total trials

What the finished NCT04161040 record still lists

NCT04161040 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Performance-based incentives is the first listed.

NCT04161040 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04161040 about?

NCT04161040 is a clinical study titled "Laboratory Model for Relapse to Sedentary Behavior". Physical inactivity is a key risk factor for noncommunicable illnesses such as cancer and cardiovascular disease-the two leading causes of death in West Virginia. The World Health Organization recommends muscle-strengthening activities 2 or more days per week and a minimum of either 150 minutes of m...

What is the current status of trial NCT04161040?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2019-12-09. Estimated completion is 2022-03-15.

What interventions are being tested in trial NCT04161040?

The interventions under investigation include: Performance-based incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT04161040?

This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04161040's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04161040, the US trial registry maintained by the National Library of Medicine. NCT04161040 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.